Literature DB >> 21363929

Negative gating modulation by (R)-N-(benzimidazol-2-yl)-1,2,3,4-tetrahydro-1-naphthylamine (NS8593) depends on residues in the inner pore vestibule: pharmacological evidence of deep-pore gating of K(Ca)2 channels.

David Paul Jenkins1, Dorte Strøbæk, Charlotte Hougaard, Marianne L Jensen, Rene Hummel, Ulrik S Sørensen, Palle Christophersen, Heike Wulff.   

Abstract

Acting as a negative gating modulator, (R)-N-(benzimidazol-2-yl)-1,2,3,4-tetrahydro-1-naphthylamine (NS8593) shifts the apparent Ca(2+)-dependence of the small-conductance Ca(2+)-activated K(+) channels K(Ca)2.1-2.3 to higher Ca(2+) concentrations. Similar to the positive K(Ca) channel-gating modulators 1-ethyl-2-benzimidazolinone (1-EBIO) and cyclohexyl-[2-(3,5-dimethyl-pyrazol-1-yl)-6-methylpyrimidin-4-yl]-amine (CyPPA), the binding site for NS8593 has been assumed to be located in the C-terminal region, in which these channels interact with their Ca(2+) sensor calmodulin. However, by using a progressive chimeric approach, we were able to localize the site-of-action of NS8593 to the K(Ca)2 pore. For example, when we transferred the C terminus from the NS8593-insensitive intermediate-conductance K(Ca)3.1 channel to K(Ca)2.3, the chimeric channel remained as sensitive to NS8593 as wild-type K(Ca)2.3. In contrast, when we transferred the K(Ca)2.3 pore to K(Ca)3.1, the channel became sensitive to NS8593. Using site-directed mutagenesis, we subsequently identified two specific residues in the inner vestibule of K(Ca)2.3 (Ser507 and Ala532) that determined the effect of NS8593. Mutation of these residues to the corresponding residues in K(Ca)3.1 (Thr250 and Val275) made K(Ca)2.3 insensitive to NS8593, whereas introduction of serine and alanine into K(Ca)3.1 was sufficient to render this channel highly sensitive to NS8593. It is noteworthy that the same two residue positions have been found previously to mediate sensitivity of K(Ca)3.1 to clotrimazole and 1-[(2-chlorophenyl)diphenylmethyl]-1H-pyrazole (TRAM-34). The location of Ser507 in the pore-loop near the selectivity filter and Ala532 in an adjacent position in S6 are within the region predicted to contain the K(Ca)2 channel gate. Hence, we propose that NS8593-mediated gating modulation occurs via interaction with gating structures at a position deep within the inner pore vestibule.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21363929      PMCID: PMC3102549          DOI: 10.1124/mol.110.069807

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  41 in total

1.  Inwardly rectifying current-voltage relationship of small-conductance Ca2+-activated K+ channels rendered by intracellular divalent cation blockade.

Authors:  H Soh; C S Park
Journal:  Biophys J       Date:  2001-05       Impact factor: 4.033

2.  Structure-guided transformation of charybdotoxin yields an analog that selectively targets Ca(2+)-activated over voltage-gated K(+) channels.

Authors:  H Rauer; M D Lanigan; M W Pennington; J Aiyar; S Ghanshani; M D Cahalan; R S Norton; K G Chandy
Journal:  J Biol Chem       Date:  2000-01-14       Impact factor: 5.157

3.  ATP-dependent activation of the intermediate conductance, Ca2+-activated K+ channel, hIK1, is conferred by a C-terminal domain.

Authors:  A C Gerlach; C A Syme; L Giltinan; J P Adelman; D C Devors
Journal:  J Biol Chem       Date:  2001-06-15       Impact factor: 5.157

4.  A human intermediate conductance calcium-activated potassium channel.

Authors:  T M Ishii; C Silvia; B Hirschberg; C T Bond; J P Adelman; J Maylie
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-14       Impact factor: 11.205

Review 5.  Pharmacology of benzodiazepine receptors: an update.

Authors:  W Sieghart
Journal:  J Psychiatry Neurosci       Date:  1994-01       Impact factor: 6.186

6.  Pharmacological modulation of SK3 channels.

Authors:  M Grunnet; T Jespersen; K Angelo; C Frøkjaer-Jensen; D A Klaerke; S P Olesen; B S Jensen
Journal:  Neuropharmacology       Date:  2001-06       Impact factor: 5.250

7.  Control of electrical activity in central neurons by modulating the gating of small conductance Ca2+-activated K+ channels.

Authors:  P Pedarzani; J Mosbacher; A Rivard; L A Cingolani; D Oliver; M Stocker; J P Adelman; B Fakler
Journal:  J Biol Chem       Date:  2000-12-27       Impact factor: 5.157

8.  Delineation of the clotrimazole/TRAM-34 binding site on the intermediate conductance calcium-activated potassium channel, IKCa1.

Authors:  H Wulff; G A Gutman; M D Cahalan; K G Chandy
Journal:  J Biol Chem       Date:  2001-06-25       Impact factor: 5.157

9.  Bicuculline methiodide potentiates NMDA-dependent burst firing in rat dopamine neurons by blocking apamin-sensitive Ca2+-activated K+ currents.

Authors:  S W Johnson; V Seutin
Journal:  Neurosci Lett       Date:  1997-08-01       Impact factor: 3.046

10.  Maurotoxin: a potent inhibitor of intermediate conductance Ca2+-activated potassium channels.

Authors:  N A Castle; D O London; C Creech; Z Fajloun; J W Stocker; J-M Sabatier
Journal:  Mol Pharmacol       Date:  2003-02       Impact factor: 4.436

View more
  24 in total

1.  Endogenous and Agonist-induced Opening of Mitochondrial Big Versus Small Ca2+-sensitive K+ Channels on Cardiac Cell and Mitochondrial Protection.

Authors:  David F Stowe; Meiying Yang; James S Heisner; Amadou K S Camara
Journal:  J Cardiovasc Pharmacol       Date:  2017-11       Impact factor: 3.105

Review 2.  Pharmacological gating modulation of small- and intermediate-conductance Ca(2+)-activated K(+) channels (KCa2.x and KCa3.1).

Authors:  Palle Christophersen; Heike Wulff
Journal:  Channels (Austin)       Date:  2015-07-28       Impact factor: 2.581

Review 3.  The therapeutic potential of small-conductance KCa2 channels in neurodegenerative and psychiatric diseases.

Authors:  Jenny Lam; Nichole Coleman; April Lourdes A Garing; Heike Wulff
Journal:  Expert Opin Ther Targets       Date:  2013-07-25       Impact factor: 6.902

4.  Identity and function of a cardiac mitochondrial small conductance Ca2+-activated K+ channel splice variant.

Authors:  MeiYing Yang; Amadou K S Camara; Mohammed Aldakkak; Wai-Meng Kwok; David F Stowe
Journal:  Biochim Biophys Acta Bioenerg       Date:  2017-03-22       Impact factor: 3.991

5.  Natural and synthetic modulators of SK (K(ca)2) potassium channels inhibit magnesium-dependent activity of the kinase-coupled cation channel TRPM7.

Authors:  V Chubanov; M Mederos y Schnitzler; M Meißner; S Schäfer; K Abstiens; T Hofmann; T Gudermann
Journal:  Br J Pharmacol       Date:  2012-06       Impact factor: 8.739

6.  Hydrophobic interactions between the S5 segment and the pore helix stabilizes the closed state of Slo2.1 potassium channels.

Authors:  Tomoyuki Suzuki; Angela Hansen; Michael C Sanguinetti
Journal:  Biochim Biophys Acta       Date:  2015-12-23

7.  A new negative allosteric modulator, AP14145, for the study of small conductance calcium-activated potassium (KCa 2) channels.

Authors:  Rafel Simó-Vicens; Jeppe E Kirchhoff; Bernardo Dolce; Lea Abildgaard; Tobias Speerschneider; Ulrik S Sørensen; Morten Grunnet; Jonas G Diness; Bo H Bentzen
Journal:  Br J Pharmacol       Date:  2017-10-22       Impact factor: 8.739

8.  NS6180, a new K(Ca) 3.1 channel inhibitor prevents T-cell activation and inflammation in a rat model of inflammatory bowel disease.

Authors:  D Strøbæk; D T Brown; D P Jenkins; Y-J Chen; N Coleman; Y Ando; P Chiu; S Jørgensen; J Demnitz; H Wulff; P Christophersen
Journal:  Br J Pharmacol       Date:  2013-01       Impact factor: 8.739

Review 9.  Trafficking of intermediate (KCa3.1) and small (KCa2.x) conductance, Ca(2+)-activated K(+) channels: a novel target for medicinal chemistry efforts?

Authors:  Corina M Balut; Kirk L Hamilton; Daniel C Devor
Journal:  ChemMedChem       Date:  2012-08-07       Impact factor: 3.466

10.  Protection against cardiac injury by small Ca(2+)-sensitive K(+) channels identified in guinea pig cardiac inner mitochondrial membrane.

Authors:  David F Stowe; Ashish K Gadicherla; Yifan Zhou; Mohammed Aldakkak; Qunli Cheng; Wai-Meng Kwok; Ming Tao Jiang; James S Heisner; Meiying Yang; Amadou K S Camara
Journal:  Biochim Biophys Acta       Date:  2012-09-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.